Tag: Pfizer
Pfizer Completes Acquisition Of ReViral
Pfizer announced the successful completion of its acquisition of ReViral, a privately held, clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel antiviral...
Pfizer To Buy Biohaven For $11.6B In Its Biggest Deal Since...
Pfizer will pay $11.6 billion to buy migraine pill maker Biohaven Pharmaceutical, marking the biggest deal by the cash-rich drugmaker since 2016 to beef...
GlaxoSmithKline & Pfizer Are Holding Out For Higher Bid In Joint...
GlaxoSmithKline (GSK) and Pfizer are holding out for an improved bid of at least £60 billion (US$82 billion) for their consumer healthcare joint venture,...
US Court OKs Pfizer’s $345M EpiPen Settlement
The EpiPen buyers leading price-gouging litigation against two top drugmakers secured final approval Wednesday from a federal judge in Kansas for their $345 million...
Merck, Pfizer’s Wyeth Settle Vaccine Patent Case
Merck Sharp & Dohme Corp and Pfizer's Wyeth subsidiary have resolved a patent dispute over their competing vaccines for preventing diseases including pneumonia and...
Pfizer To Buy Cancer Drugmaker Trillium For $2.3B
Pfizer stated on Monday, August 23, it would buy Canadian drug developer Trillium Therapeutics in a US$2.26 billion deal to strengthen its arsenal of...
UK Accuses Pfizer & Flynn Of Overcharging NHS For Anti-Epilepsy Drugs
Pharmaceutical companies Pfizer and Flynn have been accused by the UK’s competition watchdog of illegally overcharging the National Health Service (NHS) for vital anti-epilepsy...
Pfizer, Johnson & Johnson Settle Remicade Antitrust Suit
Pfizer settled with Johnson & Johnson, ending a four-year battle over J&J’s alleged use of exclusionary contracts to block biosimilar competition to its immunosuppressive...
Pfizer Pays To Exit EpiPen Price-Gouging Case
Pfizer and two subsidiaries will pay $345 million to escape antitrust litigation over an alleged scheme to gouge purchasers of the EpiPen, a lifesaving...
Request To Create California Subclass In Lipitor Antitrust Case Refused
A federal judge has refused to create a California subclass within a nationwide proposed class action accusing Pfizer of obtaining a fraudulent patent and...
